Framingham risk score and prediction of coronary heart disease death in young men

Jarett D. Berry, Donald M. Lloyd-Jones, Daniel B. Garside, Philip Greenland

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Background: We tested the ability of the Framingham Risk Score (FRS) and the online ATP III risk estimator to estimate risk and to predict 10-year and longer-term coronary heart disease (CHD) death in younger adults (age 18-39 years). Although prediction with individual risk factors has been tested in individuals <30 years, current multivariate risk prediction strategies have not been applied to prediction of clinical CHD in this age range. Methods: We included 10 551 male participants of the CHA study who were aged 18 to 39 years and free of baseline CHD and diabetes at enrollment from 1967 to 1973. Risk of CHD was estimated using both FRS and ATP III online risk estimator for each individual. Men were stratified into deciles according to the magnitude of predicted risk calculated from measured baseline risk factors (CHA-predicted risk). Observed CHD mortality rates for 10, 20, and 30 years of follow-up were compared with estimated risks. Death rates of CHD were low across 30 years of follow-up. Results: The FRS remained <10% for all deciles of CHA-predicted risk in the 18- to 29-year-old cohort. Framingham-predicted risk reached 12% only in the 30- to 39-year-old cohort in the highest decile of CHA-predicted risk despite substantial risk factor burden. Conclusions: Neither method classified individuals <30 years as high risk despite substantial risk factor burden. Future clinical guidelines should consider alternative strategies to estimate and communicate risk in populations <30 years.

Original languageEnglish (US)
Pages (from-to)80-86
Number of pages7
JournalAmerican Heart Journal
Volume154
Issue number1
DOIs
StatePublished - Jul 2007

Fingerprint

Coronary Disease
Adenosine Triphosphate
Mortality
Young Adult

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Framingham risk score and prediction of coronary heart disease death in young men. / Berry, Jarett D.; Lloyd-Jones, Donald M.; Garside, Daniel B.; Greenland, Philip.

In: American Heart Journal, Vol. 154, No. 1, 07.2007, p. 80-86.

Research output: Contribution to journalArticle

Berry, Jarett D. ; Lloyd-Jones, Donald M. ; Garside, Daniel B. ; Greenland, Philip. / Framingham risk score and prediction of coronary heart disease death in young men. In: American Heart Journal. 2007 ; Vol. 154, No. 1. pp. 80-86.
@article{5b3032afacf84e63aaf6a12c50889164,
title = "Framingham risk score and prediction of coronary heart disease death in young men",
abstract = "Background: We tested the ability of the Framingham Risk Score (FRS) and the online ATP III risk estimator to estimate risk and to predict 10-year and longer-term coronary heart disease (CHD) death in younger adults (age 18-39 years). Although prediction with individual risk factors has been tested in individuals <30 years, current multivariate risk prediction strategies have not been applied to prediction of clinical CHD in this age range. Methods: We included 10 551 male participants of the CHA study who were aged 18 to 39 years and free of baseline CHD and diabetes at enrollment from 1967 to 1973. Risk of CHD was estimated using both FRS and ATP III online risk estimator for each individual. Men were stratified into deciles according to the magnitude of predicted risk calculated from measured baseline risk factors (CHA-predicted risk). Observed CHD mortality rates for 10, 20, and 30 years of follow-up were compared with estimated risks. Death rates of CHD were low across 30 years of follow-up. Results: The FRS remained <10{\%} for all deciles of CHA-predicted risk in the 18- to 29-year-old cohort. Framingham-predicted risk reached 12{\%} only in the 30- to 39-year-old cohort in the highest decile of CHA-predicted risk despite substantial risk factor burden. Conclusions: Neither method classified individuals <30 years as high risk despite substantial risk factor burden. Future clinical guidelines should consider alternative strategies to estimate and communicate risk in populations <30 years.",
author = "Berry, {Jarett D.} and Lloyd-Jones, {Donald M.} and Garside, {Daniel B.} and Philip Greenland",
year = "2007",
month = "7",
doi = "10.1016/j.ahj.2007.03.042",
language = "English (US)",
volume = "154",
pages = "80--86",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Framingham risk score and prediction of coronary heart disease death in young men

AU - Berry, Jarett D.

AU - Lloyd-Jones, Donald M.

AU - Garside, Daniel B.

AU - Greenland, Philip

PY - 2007/7

Y1 - 2007/7

N2 - Background: We tested the ability of the Framingham Risk Score (FRS) and the online ATP III risk estimator to estimate risk and to predict 10-year and longer-term coronary heart disease (CHD) death in younger adults (age 18-39 years). Although prediction with individual risk factors has been tested in individuals <30 years, current multivariate risk prediction strategies have not been applied to prediction of clinical CHD in this age range. Methods: We included 10 551 male participants of the CHA study who were aged 18 to 39 years and free of baseline CHD and diabetes at enrollment from 1967 to 1973. Risk of CHD was estimated using both FRS and ATP III online risk estimator for each individual. Men were stratified into deciles according to the magnitude of predicted risk calculated from measured baseline risk factors (CHA-predicted risk). Observed CHD mortality rates for 10, 20, and 30 years of follow-up were compared with estimated risks. Death rates of CHD were low across 30 years of follow-up. Results: The FRS remained <10% for all deciles of CHA-predicted risk in the 18- to 29-year-old cohort. Framingham-predicted risk reached 12% only in the 30- to 39-year-old cohort in the highest decile of CHA-predicted risk despite substantial risk factor burden. Conclusions: Neither method classified individuals <30 years as high risk despite substantial risk factor burden. Future clinical guidelines should consider alternative strategies to estimate and communicate risk in populations <30 years.

AB - Background: We tested the ability of the Framingham Risk Score (FRS) and the online ATP III risk estimator to estimate risk and to predict 10-year and longer-term coronary heart disease (CHD) death in younger adults (age 18-39 years). Although prediction with individual risk factors has been tested in individuals <30 years, current multivariate risk prediction strategies have not been applied to prediction of clinical CHD in this age range. Methods: We included 10 551 male participants of the CHA study who were aged 18 to 39 years and free of baseline CHD and diabetes at enrollment from 1967 to 1973. Risk of CHD was estimated using both FRS and ATP III online risk estimator for each individual. Men were stratified into deciles according to the magnitude of predicted risk calculated from measured baseline risk factors (CHA-predicted risk). Observed CHD mortality rates for 10, 20, and 30 years of follow-up were compared with estimated risks. Death rates of CHD were low across 30 years of follow-up. Results: The FRS remained <10% for all deciles of CHA-predicted risk in the 18- to 29-year-old cohort. Framingham-predicted risk reached 12% only in the 30- to 39-year-old cohort in the highest decile of CHA-predicted risk despite substantial risk factor burden. Conclusions: Neither method classified individuals <30 years as high risk despite substantial risk factor burden. Future clinical guidelines should consider alternative strategies to estimate and communicate risk in populations <30 years.

UR - http://www.scopus.com/inward/record.url?scp=34250311635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250311635&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2007.03.042

DO - 10.1016/j.ahj.2007.03.042

M3 - Article

C2 - 17584558

AN - SCOPUS:34250311635

VL - 154

SP - 80

EP - 86

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1

ER -